8 trends tracked about this subject — the full history, oldest to newest below.
The FDA approval of a landmark pancreatic cancer drug costing $480,000 annually signals a shifting economic landscape for oncology treatments.
2 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Novartis shares climb following positive late-stage trial results for its experimental oral multiple sclerosis drug, Rhapsido.
13 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
2 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
7 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
5 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
The FDA has approved a first-of-its-kind daily oral pill from Merck designed to slash cholesterol levels.